News & EventsMacroCure will be presented at ILSI - Biomed congress Dr. Mitchell Shirvan, MacroCure's CEO, will present the company during the ILSI - Biomed congress on the 16th of June, 11:00 at Hall B
Dr. Alan Smith joined MacroCure Alan Smith, Ph.D, Joined MacroCure as Head of US Operations
MacroCure at Conferences
Over 5,000 patients treated in Israel April 2010 Over the past 10 years, more than 5,000 patients in Israel have been treated with CureXcell™ for a variety of chronic wounds. No significant adverse events have been reported with the use of CureXcell™.
|